NEW Dividiend Portfolio Tracker (DRIPTracker) is Now Live!
Track your stocks, dividends, monitor DRIP shares, and project your passive income.
Start Free »

Eli Lilly and Company LLY | NYSE

$1,180.16 $0.00 | 0.00%

Next Earnings: Aug 15, 2026

Company Overview:

Market Cap: $0
Trailing PE: 0x
52-Week Range: $685.15 - $1,249.45

10 Year LLY Performance Metrics:

Total Return (with DRIP): 1,623% (32.93% CAGR)
Total Return (no DRIP): 1,417% (31.25% CAGR)
Share Price: 1,370% (30.84% CAGR)
Dividend Increase: 239.2% (12.99% CAGR)
Dividend Yield (FWD): 0.59% ($6.92)
LLY 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

LLY Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
LLY Dividend CAGR:1Y: 15.33%2Y: 15.36%5Y: 15.27%10Y: 12.99%
Share Price
LLY Price CAGR:1Y: 72.43%2Y: 12.55%5Y: 34.90%10Y: 30.84%

Unlock All Reports & Research Dividend Stocks.

[lev_ptables no_sale]

LLY Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - LLY
7-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - LLY
7-Day FREE Trial Get Full Access Now!

LLY Earnings, Revenue, Cash & Debt, Shares Outstaning:

LLY - Revenue
7-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 47.67%2Y: 42.57%5Y: 27.80%10Y: 15.57%
LLY - Earnings Per Share (EPS)
7-Day FREE Trial Get Full Access Now!
LLY EPS CAGR:1Y: 26.23%2Y: 55.59%5Y: 39.00%10Y: 27.31%
LLY - Net Income
7-Day FREE Trial Get Full Access Now!
LLY Net Income CAGR:1Y: 25.34%2Y: 54.64%5Y: 38.54%10Y: 25.23%
LLY - EBITDA
7-Day FREE Trial Get Full Access Now!
LLY EBITDA CAGR:1Y: 23.23%2Y: 49.90%5Y: 37.82%10Y: 24.43%
LLY - Free Cash Flow
7-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow CAGR:1Y: 504.60%2Y: 1,006.12%5Y: 44.20%10Y: 20.96%
LLY - Free Cash Flow / Share
7-Day FREE Trial Get Full Access Now!
LLY Free Cash Flow / Share CAGR:1Y: 508.32%2Y: 1,011.38%5Y: 44.68%10Y: 23.04%
LLY - Operating Income
7-Day FREE Trial Get Full Access Now!
LLY Operating Income CAGR:1Y: 25.99%2Y: 42.55%5Y: 44.43%10Y: 25.54%
LLY - Gross Profit
7-Day FREE Trial Get Full Access Now!
LLY Gross Profit CAGR:1Y: 50.31%2Y: 46.89%5Y: 32.71%10Y: 17.47%
LLY - Shares Outstanding
7-Day FREE Trial Get Full Access Now!
LLY Shares Outstanding CAGR:1Y: -0.68%2Y: -0.58%5Y: -0.37%10Y: -1.69%
LLY - Share Buybacks
7-Day FREE Trial Get Full Access Now!
LLY Share Buybacks CAGR:1Y: 131.29%2Y: 0.00%5Y: 26.21%10Y: 0.00%
LLY - Stock-Based Comp
7-Day FREE Trial Get Full Access Now!
LLY Stock-Based Comp CAGR:1Y: 8.59%2Y: -2.42%5Y: 16.94%10Y: 11.95%
LLY - Expenses
7-Day FREE Trial Get Full Access Now!
LLY Expenses CAGR:1Y: 62.59%2Y: 44.60%5Y: 40.73%10Y: 28.16%
LLY - Revenue vs Net Income
7-Day FREE Trial Get Full Access Now!
LLY - EPS vs FCF / Share
7-Day FREE Trial Get Full Access Now!
LLY - EPS vs PE Ratio
7-Day FREE Trial Get Full Access Now!
LLY - FCF vs FCF / Share
7-Day FREE Trial Get Full Access Now!
LLY - FCF vs Stock Based Comp
7-Day FREE Trial Get Full Access Now!
LLY - Cash & Debt
7-Day FREE Trial Get Full Access Now!
LLY - Dividends
7-Day FREE Trial Get Full Access Now!
LLY Dividend CAGR:1Y: 15.33%2Y: 15.36%5Y: 15.27%10Y: 12.99%
LLY - Revenue by Segment
7-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 47.67%2Y: 42.57%5Y: 27.80%10Y: 15.57%
LLY - Revenue by Region
7-Day FREE Trial Get Full Access Now!
LLY Revenue CAGR:1Y: 47.67%2Y: 42.57%5Y: 27.80%10Y: 15.57%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

LLY - REVENUE: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
LLY Actual Revenue CAGR:1Y: 47.67%2Y: 42.57%5Y: 27.80%10Y: 15.57%
LLY - EPS: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
LLY Actual EPS CAGR:1Y: 26.23%2Y: 55.59%5Y: 39.00%10Y: 27.31%
LLY - NET INCOME: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
LLY Actual Net Income CAGR:1Y: 25.34%2Y: 54.64%5Y: 38.54%10Y: 25.23%
LLY - EBITDA: Actual + Estimates
7-Day FREE Trial Get Full Access Now!
LLY Actual EBITDA CAGR:1Y: 23.23%2Y: 49.90%5Y: 37.82%10Y: 24.43%

Ratios, Profit Margins & Return on Capital:

LLY - Net Profit Margin
7-Day FREE Trial Get Full Access Now!
LLY Net Profit Margin CAGR:1Y: -15.12%2Y: 8.46%5Y: 8.40%10Y: 8.36%
LLY - Gross Profit Margin
7-Day FREE Trial Get Full Access Now!
LLY Gross Profit Margin CAGR:1Y: 1.79%2Y: 3.04%5Y: 3.85%10Y: 1.64%
LLY - Price to Earnings
7-Day FREE Trial Get Full Access Now!
LLY - Price To Sales Ratio
7-Day FREE Trial Get Full Access Now!
LLY - Return on Capital Employed
7-Day FREE Trial Get Full Access Now!
LLY - Return on Invested Capital
7-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

LLY Dividends Info:

Annual Dividend: $6.92
Forward Yield: 0.59%
Ex-Dividend Date: 2026-08-14
Lifetime Dividends / Share: $75.94

LLY Dividend History: Dates, Payments & Yield list

Below is a schedule of all LLY dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
08/14/202609/10/2026$1.7300.57%0%$0.00
05/15/202606/10/2026$1.7300.64%0.61%$1,136.37
02/13/202603/10/2026$1.7300.6%0.69%$1,001.35
11/14/202512/10/2025$1.5000.59%0.6%$993.64
08/15/202509/10/2025$1.5000.83%0.8%$754.62
05/16/202506/10/2025$1.5000.74%0.74%$807.19
02/14/202503/10/2025$1.5000.64%0.72%$829.76
11/15/202412/10/2024$1.3000.7%0.65%$799.58
08/15/202409/10/2024$1.3000.54%0.58%$901.25
05/15/202406/10/2024$1.3000.62%0.6%$865.00
02/14/202403/08/2024$1.3000.62%0.68%$762.14
11/14/202312/08/2023$1.1300.74%0.76%$598.05
08/14/202309/08/2023$1.1300.81%0.77%$586.46
05/12/202306/09/2023$1.1300.75%1.01%$446.04
02/14/202303/10/2023$1.1300.61%1.43%$315.02
11/14/202212/09/2022$0.9801.1%1.09%$360.99
08/12/202209/09/2022$0.9801.23%1.23%$317.70
05/13/202206/10/2022$0.9801.26%1.32%$297.01
02/14/202203/10/2022$0.9801.5%1.47%$266.02
11/12/202112/10/2021$0.8501.31%1.39%$244.14
08/12/202109/10/2021$0.8501.25%1.42%$239.50
05/13/202106/10/2021$0.8501.63%1.46%$233.54
02/11/202103/10/2021$0.8501.52%1.65%$205.45
11/12/202012/10/2020$0.7402.1%1.84%$161.00
08/13/202009/10/2020$0.7401.9%2.02%$146.22
05/14/202006/10/2020$0.7401.75%1.96%$151.00
02/13/202003/10/2020$0.7401.89%2.1%$141.19
11/14/201912/10/2019$0.6452.32%2.14%$120.65
08/14/201909/10/2019$0.6452.26%2.32%$111.10
05/16/201906/10/2019$0.6452.07%2.26%$113.93
02/14/201903/08/2019$0.6451.93%2.04%$126.70
11/14/201812/10/2018$0.5632.05%1.97%$114.09
08/14/201809/10/2018$0.5632.15%2.11%$106.42
05/16/201806/08/2018$0.5632.67%2.61%$86.08
02/14/201803/09/2018$0.5632.76%2.83%$79.61
11/14/201712/08/2017$0.5202.52%2.41%$86.45
08/11/201709/08/2017$0.5202.55%2.51%$82.92
05/11/201706/09/2017$0.5202.57%2.57%$81.04
02/13/201703/10/2017$0.5202.64%2.47%$84.36
11/10/201612/09/2016$0.5102.6%3.01%$67.85
08/11/201609/09/2016$0.5102.52%2.61%$78.24
05/11/201606/10/2016$0.5102.65%2.76%$73.95
02/10/201603/10/2016$0.5102.75%2.79%$73.02
11/10/201512/10/2015$0.5002.5%2.36%$84.91
08/12/201509/10/2015$0.5002.39%2.47%$80.84
05/14/201506/10/2015$0.5002.71%2.4%$83.18
02/11/201503/10/2015$0.5002.82%2.91%$68.78
11/12/201412/10/2014$0.4902.91%2.76%$71.05
08/13/201409/10/2014$0.4903.23%3.03%$64.78
05/13/201406/10/2014$0.4903.26%3.28%$59.75
02/12/201403/10/2014$0.4903.68%3.33%$58.90
11/13/201312/10/2013$0.4903.88%3.88%$50.49
08/13/201309/10/2013$0.4903.57%3.71%$52.87
05/14/201306/10/2013$0.4903.51%3.72%$52.64
02/13/201303/08/2013$0.4903.67%3.55%$55.16
11/13/201212/10/2012$0.4904.16%3.91%$50.12
08/13/201209/10/2012$0.4904.58%4.21%$46.52
05/11/201206/08/2012$0.4904.75%4.72%$41.53
02/13/201203/09/2012$0.4905.05%4.95%$39.56
11/10/201112/09/2011$0.4905.26%4.99%$39.27
08/11/201109/09/2011$0.4905.55%5.42%$36.13
05/11/201106/10/2011$0.4905.12%5.29%$37.05
02/11/201103/10/2011$0.4905.68%5.64%$34.77
11/10/201012/10/2010$0.4905.6%5.6%$34.98
08/11/201009/10/2010$0.4905.34%5.53%$35.43
05/12/201006/10/2010$0.4905.64%5.86%$33.46
02/10/201003/10/2010$0.4905.74%5.55%$35.34
11/10/200912/10/2009$0.4905.56%5.6%$35.02
08/12/200909/10/2009$0.4905.89%5.97%$32.82
05/13/200906/10/2009$0.4905.46%5.78%$33.91
02/11/200903/10/2009$0.4905.17%6.59%$29.72
11/12/200812/10/2008$0.4705.88%5.37%$35.01
08/13/200809/10/2008$0.4703.79%4.02%$46.73
05/13/200806/10/2008$0.4703.76%3.92%$47.94
02/13/200803/10/2008$0.4703.47%3.8%$49.42
11/13/200712/10/2007$0.4253.23%3.1%$54.78
08/13/200709/10/2007$0.4252.94%3.03%$56.14
05/11/200706/08/2007$0.4252.82%2.98%$57.02
02/13/200703/09/2007$0.4252.99%3.23%$52.59
11/13/200612/08/2006$0.4002.96%2.96%$54.00
08/11/200609/08/2006$0.4002.91%2.9%$55.26
05/11/200606/09/2006$0.4003.05%3.09%$51.74
02/13/200603/10/2006$0.4002.78%2.79%$57.25
11/10/200512/09/2005$0.3802.96%2.85%$53.41
08/11/200509/09/2005$0.3802.79%2.68%$56.72
05/11/200506/10/2005$0.3802.5%2.67%$56.99
02/11/200503/10/2005$0.3802.6%2.74%$55.56
11/10/200412/10/2004$0.3552.55%2.58%$55.04
08/11/200409/10/2004$0.3552.24%2.16%$65.85
05/12/200406/10/2004$0.3551.87%1.93%$73.64
02/11/200403/10/2004$0.3551.82%2.01%$70.49
11/12/200312/10/2003$0.3352.02%1.9%$70.40
08/13/200309/10/2003$0.3352.11%2.16%$62.03
05/13/200306/10/2003$0.3352.02%2.22%$60.23
02/12/200303/10/2003$0.3352.15%2.39%$56.00
11/13/200212/10/2002$0.3102.06%1.88%$66.10
08/13/200209/10/2002$0.3102.16%2.14%$57.81
05/13/200206/10/2002$0.3101.83%2.02%$61.31
02/13/200203/08/2002$0.3101.51%1.59%$78.20
11/13/200112/10/2001$0.2801.42%1.37%$81.54
08/13/200109/10/2001$0.2801.4%1.45%$77.20
05/11/200106/11/2001$0.2801.29%1.29%$87.00
02/13/200103/09/2001$0.2801.33%1.42%$79.00
11/13/200012/11/2000$0.2601.21%1.12%$92.88
08/11/200009/11/2000$0.2601.31%1.48%$70.25
05/11/200006/09/2000$0.2601.31%1.37%$76.19
02/11/200003/10/2000$0.2601.54%1.7%$61.19
11/10/199912/10/1999$0.2301.21%1.4%$65.88
08/11/199909/10/1999$0.2301.45%1.27%$72.38
05/12/199906/10/1999$0.2301.13%1.3%$70.69
02/10/199903/10/1999$0.2300.95%1%$91.81
11/10/199812/10/1998$0.2000.93%0.92%$86.81
08/12/199809/10/1998$0.2001.17%1.1%$72.81
05/13/199806/10/1998$0.2001.14%1.26%$63.38
02/11/199803/10/1998$0.2001.15%1.2%$66.44
11/12/199712/10/1997$0.2001.17%1.26%$63.31
08/13/199709/10/1997$0.1801.36%1.37%$52.59
05/13/199706/10/1997$0.1801.51%1.44%$50.00
02/12/199703/10/1997$0.1801.53%1.57%$45.75
11/13/199612/10/1996$0.1711.81%1.83%$37.44
08/13/199609/10/1996$0.1712.32%2.31%$29.63
05/13/199606/10/1996$0.1712.42%2.06%$33.31
02/13/199603/11/1996$0.1712.07%2.14%$32.00
11/13/199512/11/1995$0.1712.72%2.7%$25.41
08/11/199509/11/1995$0.1613.37%3.1%$20.81
05/09/199506/12/1995$0.1613.47%3.39%$19.00
02/09/199503/10/1995$0.1613.84%3.79%$17.03
11/08/199412/12/1994$0.1563.96%3.99%$15.66
08/09/199409/12/1994$0.1565.09%4.44%$14.09
05/09/199406/10/1994$0.1564.63%4.38%$14.28
02/09/199403/10/1994$0.1564.22%4.8%$13.03
11/08/199312/10/1993$0.1514.34%4.23%$14.31
08/09/199309/10/1993$0.1515.33%5.02%$12.06
05/10/199306/10/1993$0.1514.55%4.89%$12.38
02/09/199303/10/1993$0.1514.15%4.55%$13.31
11/06/199212/10/1992$0.1383.59%3.37%$16.31
08/10/199209/10/1992$0.1383.08%3.29%$16.72
05/11/199206/10/1992$0.1383.12%3.4%$16.16
02/10/199203/10/1992$0.1382.59%3.05%$18.06
11/08/199112/10/1991$0.1252.63%2.7%$18.53
08/09/199109/10/1991$0.1252.41%2.49%$20.06
05/09/199106/10/1991$0.1252.36%2.62%$19.09
02/07/199103/11/1991$0.1252.34%2.4%$20.81
11/08/199012/10/1990$0.1032.39%2.15%$19.06
08/09/199009/10/1990$0.1032.01%2.18%$18.81
05/09/199006/11/1990$0.1032.17%2.14%$19.19
02/09/199003/12/1990$0.1032.26%2.6%$15.75
11/09/198912/11/1989$0.0842.11%2.09%$16.16
08/09/198909/11/1989$0.0842.12%2.23%$15.09
05/09/198906/12/1989$0.0842.37%2.37%$14.19
02/09/198903/10/1989$0.0842.53%2.73%$12.38
11/08/198812/12/1988$0.0722.64%2.62%$10.98
08/09/198809/12/1988$0.0722.67%2.66%$10.81
05/09/198806/10/1988$0.0722.78%2.73%$10.53
02/09/198803/10/1988$0.0722.84%2.96%$9.70
11/06/198712/10/1987$0.0632.65%2.92%$8.56
08/10/198709/10/1987$0.0631.97%2.12%$11.78
05/11/198706/10/1987$0.0632.19%2.13%$11.75
02/09/198703/10/1987$0.0632.18%2.04%$12.25
11/07/198611/12/1986$0.0562.41%2.37%$9.50
08/11/198608/13/1986$0.0562.3%2.26%$9.94
05/09/198605/14/1986$0.0562.41%2.63%$8.56
02/10/198602/12/1986$0.0562.95%3.21%$7.02
11/08/198511/13/1985$0.0503.36%3.22%$6.22
08/09/198508/14/1985$0.0503.85%3.77%$5.31
05/09/198505/13/1985$0.0503.97%4.07%$4.91
02/08/198502/13/1985$0.0504.19%4.36%$4.59
11/08/198411/12/1984$0.0504.73%5.1%$3.92
08/09/198408/13/1984$0.0454.97%5.05%$3.59
05/09/198405/11/1984$0.0454.66%4.64%$3.91
02/08/198402/10/1984$0.0454.6%4.67%$3.88
11/07/198311/09/1983$0.0450%4.8%$3.78
08/09/198308/11/1983$0.0450%4.8%$3.78
05/09/198305/11/1983$0.0410%4.3%$3.78
02/09/198302/11/1983$0.0410%4.3%$3.78
11/05/198211/10/1982$0.0410%4.3%$3.78
08/09/198208/11/1982$0.0410%4.3%$3.78
05/10/198205/12/1982$0.0410%4.3%$3.78
02/08/198202/10/1982$0.0410%4.3%$3.78
11/06/198111/11/1981$0.0360%3.8%$3.78
08/10/198108/12/1981$0.0360%3.8%$3.78
05/11/198105/13/1981$0.0360%3.8%$3.78
02/05/198102/09/1981$0.0360%3.8%$3.78
11/07/198011/12/1980$0.0360%3.8%$3.78
08/11/198008/13/1980$0.0360%3.8%$3.78
05/12/198005/14/1980$0.0330%3.47%$3.78
02/08/198002/13/1980$0.0330%3.47%$3.78
11/02/197911/07/1979$0.0330%3.47%$3.78
08/06/197908/08/1979$0.0330%3.47%$3.78
05/07/197905/09/1979$0.0280%2.98%$3.78
02/05/197902/07/1979$0.0280%2.98%$3.78
11/03/197811/08/1978$0.0280%2.98%$3.78
08/07/197808/09/1978$0.0250%2.65%$3.78
05/08/197805/10/1978$0.0250%2.65%$3.78
02/06/197802/08/1978$0.0250%2.65%$3.78
11/03/197711/07/1977$0.0220%2.35%$3.78
08/08/197708/10/1977$0.0220%2.35%$3.78
05/09/197705/11/1977$0.0220%2.35%$3.78
02/04/197702/09/1977$0.0220%2.35%$3.78
11/05/197611/10/1976$0.0200%2.15%$3.78
08/09/197608/11/1976$0.0200%2.15%$3.78
05/10/197605/12/1976$0.0190%1.98%$3.78
02/06/197602/11/1976$0.0190%1.98%$3.78
11/07/197511/12/1975$0.0170%1.82%$3.78
08/11/197508/13/1975$0.0170%1.82%$3.78
05/12/197505/14/1975$0.0170%1.82%$3.78
02/07/197502/12/1975$0.0170%1.82%$3.78
11/08/197411/13/1974$0.0160%1.65%$3.78
08/12/197408/14/1974$0.0160%1.65%$3.78
05/13/197405/15/1974$0.0150%1.55%$3.78
02/08/197402/13/1974$0.0150%1.55%$3.78
11/12/197311/14/1973$0.0130%1.37%$3.78
08/13/197308/15/1973$0.0130%1.37%$3.78
05/14/197305/16/1973$0.0120%1.25%$3.78
02/09/197302/14/1973$0.0120%1.25%$3.78
11/13/197211/15/1972$0.0110%1.2%$3.78
08/07/197208/09/1972$0.0110%1.2%$3.78

Projected Future Returns & Dividends for LLY

Based on past 10-year performance, here are LLY growth metrics:

Share price CAGR of +30.84%
Dividend CAGR of +12.99%

Using LLY CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

LLY (DRIP)LLY - No DRIP
Current Price$1,180.16$1,180.16
Start Shares8.478.47
Start Value$10,000$10,000
  
After 10 years:
Final Share Count8.768.47
Dividends Payment$5.87$5.87
Annual Dividends$206$199
Yield on cost2.06%1.99%
Share Price$17,353.32$17,353.32
Total Dividends$1,105$1,080
Final Value$151,983$148,122

Estimated Future Value + Dividends - LLY

NOTE: Above numbers are our estimate based on LLY's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

[lev_ptables no_sale]

Company Info

Eli Lilly and Company (LLY) had its IPO on 1972-06-01, and is trader on NYSE stock exchange.

Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer. For autoimmune and inflammatory conditions, the company markets Olumiant for rheumatoid arthritis, and Taltz, which addresses plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Addressing neurological and pain management needs, Eli Lilly provides Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. Emgality is available for migraine prevention and episodic cluster headaches, while Zyprexa treats schizophrenia, bipolar I disorder, and aids in bipolar maintenance. Other significant products include Bamlanivimab and etesevimab, along with Bebtelovimab, both developed for COVID-19. Cialis is offered for erectile dysfunction and benign prostatic hyperplasia, and Forteo is available for osteoporosis. Eli Lilly actively engages in strategic collaborations with numerous partners, including Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Established in 1876, Eli Lilly and Company maintains its corporate headquarters in Indianapolis, Indiana.

LLY website: https://www.lilly.com


Get Full Access to All Reports with DRIPCalc PRO

[lev_ptables no_sale]